Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

By sjmartinez • July 12, 2023

Ding L, Sun L, Bu MT, Zhang Y, Scott LN, Prins RM, Su MA, Lechner MG, Hugo W. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors. Front Immunol. 2023 Jun 26;14:1176994. doi: 10.3389/fimmu.2023.1176994. PMID: 37435085; PMCID: PMC10330698.

Tags: antigen presentation, B cell, checkpoint inhibitors, Dermatology, Endocrinology, immunotherapy, interferon gamma pathway, melanoma, Publications, T cell, tertiary lymphoid structure (TLS)

GLP-1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study

Ma EJ, Roberts AM, Jeong CY, Chou P, Katz A, Nong Y, Johnsen N, Yan M, Ochoa MT, Armstrong AW. GLP-1RAs and cardiovascular risk reduction[...]

Ethical considerations regarding environmental impact of generative artificial intelligence (AI) in dermatology

Ebriani J, Yan MJ, Lester J, Farshchian M, Wongvibulsin S. Ethical considerations regarding environmental impact of generative artificial intelligence (AI) in dermatology. J Am Acad[...]

Autoimmune Bullous Diseases: Therapeutic Update

Kasperkiewicz M, van Beek N, Schmidt E. Autoimmune Bullous Diseases: Therapeutic Update. Drugs. 2026 Feb 23. doi: 10.1007/s40265-026-02292-3. Epub ahead of print. PMID: 41729378.